07:00 , Apr 5, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Dermatology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Dermatology Alopecia Prostaglandin D2 (PGD2); prostaglandin D2 receptor (CRTH2; GPR44; CD294); prostaglandin D2 synthase (PTGDS) Mouse and human studies suggest inhibiting PGD2 signaling could help treat...
07:00 , Aug 5, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Hematopoietic prostaglandin D2 (PGD2); hematopoietic prostaglandin D2 synthase (HPGDS) A study in cell culture identified a nicotinamide-based HPGDS inhibitor that could help treat inflammation....